Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1960 Dec 10;83(24):1249–1254.

Depressive States and Drugs. III. Use of Methylphenidate (Ritalin) in Open Psychiatric Settings and in Office Practice *

A B Kerenyi, E K Koranyi, G J Sarwer-Foner
PMCID: PMC1938995  PMID: 13752603

Full text

PDF
1249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEECHER H. K. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602–1606. doi: 10.1001/jama.1955.02960340022006. [DOI] [PubMed] [Google Scholar]
  2. DAVIDOFF E., BEST J. L., MCPHEETERS H. L. The effect of ritalin (methyl-phenidylacetate hydrochloride) on mildly depressed ambulatory patients. N Y State J Med. 1957 May 15;57(10):1753–1757. [PubMed] [Google Scholar]
  3. DRASSDO A., SCHMIDT M. Ritalin, ein zentrales Stimulans mit neuratiger chemischer Konstitution. 2. Verbesserung der geistigen Leistungsfähigkeit und psychische Wirkung durch Ritalin. Med Monatsschr. 1954 Jun;8(6):393–395. [PubMed] [Google Scholar]
  4. FERGUSON J. T., FUNDERBURK W. H. Improving senile behavior with reserpine and ritalin; new approach with use of methyl phenylpiperidylacetate. J Am Med Assoc. 1956 Jan 28;160(4):259–263. doi: 10.1001/jama.1956.02960390009003. [DOI] [PubMed] [Google Scholar]
  5. FERGUSON J. T., LINN F. V., NICKELS M. M., SHEETS J. A., Jr Methylphenidate (ritalin) hydrochloride parenteral solution; preliminary report. J Am Med Assoc. 1956 Dec 1;162(14):1303–1304. doi: 10.1001/jama.1956.02970310031007. [DOI] [PubMed] [Google Scholar]
  6. FERGUSON J. T. Treatment of reserpine-induced depression with a new analeptic: phenidylate. Ann N Y Acad Sci. 1955 Apr 15;61(1):101–107. doi: 10.1111/j.1749-6632.1955.tb42456.x. [DOI] [PubMed] [Google Scholar]
  7. FREED H. The use of ritalin intravenously as a diagnostic adjuvant in psychiatry. Am J Psychiatry. 1958 Apr;114(10):944–944. doi: 10.1176/ajp.114.10.944. [DOI] [PubMed] [Google Scholar]
  8. HARTERT D., BROWNE-MAYERS A. N. The use of methylphenidate (ritalin) hydrochloride in alcoholism; preliminary report on its diagnostic and therapeutic use. J Am Med Assoc. 1958 Apr 19;166(16):1982–1985. doi: 10.1001/jama.1958.02990160040011. [DOI] [PubMed] [Google Scholar]
  9. JACOBSON A. Ritalin--a new agent for mild depressions; a preliminary report. Med Ann Dist Columbia. 1956 Sep;25(9):491–passim. [PubMed] [Google Scholar]
  10. KOVITZ B., MADI M. L. Experiences with methyl-phenidylacetate hydrochloride (ritalin) in psychotic patients. Antibiotic Med Clin Ther (New York) 1956 Oct;3(5):309–311. [PubMed] [Google Scholar]
  11. LANDMAN M. E., PREISIG R., PERLMAN M. A practical mood stimulant. J Med Soc N J. 1958 Feb;55(2):55–58. [PubMed] [Google Scholar]
  12. LASAGNA L., VON FELSINGER J. M., BEECHER H. K. Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. J Am Med Assoc. 1955 Mar 19;157(12):1006–1020. doi: 10.1001/jama.1955.02950290026009. [DOI] [PubMed] [Google Scholar]
  13. MEIER R., GROSS F., TRIPOD J. Ritalin, eine neuartige synthetische Verbindung mit spezifischer zentralerregender Wirkungskomponente. Klin Wochenschr. 1954 May 15;32(19-20):445–450. doi: 10.1007/BF01466968. [DOI] [PubMed] [Google Scholar]
  14. ROSENTHAL D., FRANK J. D. Psychotherapy and the placebo effect. Psychol Bull. 1956 Jul;53(4):294–302. doi: 10.1037/h0044068. [DOI] [PubMed] [Google Scholar]
  15. SARWER-FONER G. J., GRAUER H., MACKAY J., KORANYI E. K. Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings. Med Serv J Can. 1959 Jun;15(6):359–382. [PubMed] [Google Scholar]
  16. SARWER-FONER G. J., KORANYI E. K., MESZAROS A., GRAUER H. Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings. Can Med Assoc J. 1959 Dec 15;81:991–996. [PMC free article] [PubMed] [Google Scholar]
  17. SARWER-FONER G. J., KORANYI E. K. The clinical investigation of pacatal in open psychiatric settings. Can Med Assoc J. 1957 Sep 1;77(5):450–459. [PMC free article] [PubMed] [Google Scholar]
  18. SARWER-FONER G. J., OGLE W. The use of reserpine in an open psychiatric setting. Can Med Assoc J. 1955 Aug 1;73(3):187–191. [PMC free article] [PubMed] [Google Scholar]
  19. SARWER-FONER G. J. The transference and nonspecific drug effects in the use of the tranquilizing drugs, and their influence on affect. Psychiatr Res Rep Am Psychiatr Assoc. 1957 Dec;8:153–167. [PubMed] [Google Scholar]
  20. VON FELSINGER J. M., LASAGNA L., BEECHER H. K. Drug-induced mood changes in man. II. Personality and reactions to drugs. J Am Med Assoc. 1955 Mar 26;157(13):1113–1119. doi: 10.1001/jama.1955.02950300041009. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES